BRIEF-Clearside Biomedical Arctic Vision Says New Drug Applications For Arcatus Officially Accepted In Australia And Singapore

July 29 (Reuters) - Clearside Biomedical Inc:

* CLEARSIDE BIOMEDICAL’S PARTNER ARCTIC VISION REPORTS POSITIVE TOPLINE RESULTS FROM PHASE 3 CLINICAL TRIAL OF ARCATUS® FOR SUPRACHOROIDAL USE IN UVEITIC MACULAR EDEMA PATIENTS IN CHINA

* CLEARSIDE BIOMEDICAL: ARCTIC VISION ANNOUNCED THAT NEW DRUG APPLICATIONS FOR ARCATUS HAVE BEEN OFFICIALLY ACCEPTED IN AUSTRALIA AND SINGAPORE Source text for Eikon: Further company coverage: